| Exploring Emerging Non-Statin LDL Lowering Therapies | 04/24/2024 | |
| Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials | 04/08/2024 | |
| One Foundation's Approach to Preventing Sudden Cardiac Death in Young Athletes | | |
| Cardiac Rehabilitation: Key Considerations for Breast Cancer Survivors | 04/05/2023 | |
| Patching Up Cardiovascular Risk | | |
| Exploring the Careers of Cardiologists: A Noninvasive Cardiologist's Journey & a First-Year Student… | 04/24/2024 | |
| Considering Cannabis & the Cardiovascular System: A Look at Patient Outcomes | 04/24/2024 | |
| ASCVD Risk & Women: Investigating Impact on Female Patients | 04/25/2024 | |
| Coronary Heart Disease & Postmenopausal Women: Evaluating Risk Through Research | 04/24/2024 | |
| Exploring Strategies to Eliminate Disparities in Cardiovascular Care | 04/25/2024 | |
| Detecting & Diagnosing Diabetes in Cardiology Patients | 04/25/2024 | |
| Cardiology Among the Constellations: Exploring Microgravity & Space Flight | 04/26/2024 | |
| Assessing Advancements in Preventative Cardiology | 04/24/2024 | |
| Addressing Racial Disparities in Cardiovascular Care | 04/25/2024 | |
| At the Heart of Healthcare: Addressing the Future of Cardiology Care | 04/26/2024 | |
| Gazing into the Cardiology Crystal Ball: The Future of Preventive Care | 04/25/2024 | |
| Uncovering Evidence on Blood Pressure Improvements in Americans | 04/23/2024 | |
| How Does COVID-19 Affect the Heart? | 04/26/2024 | |
| Meet Alan Brown, MD | | |
| Treating Erectile Dysfunction: Key Cardiovascular Considerations | 04/22/2024 | |
| Pharmacometabolomics to Predict Statin Response: Ready for Prime Time? | 04/26/2024 | |
| Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines | 04/24/2024 | |
| PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects | 04/24/2024 | |
| Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease | 04/22/2024 | |
| Canadian Perspectives on Managing Lipid Disorders in Children | 04/25/2024 | |
| Lipid-Lowering Drug Interactions in Cardiovascular Agents | 04/22/2024 | |
| Selecting the Right Contraception for the Dyslipidemic Woman | 04/23/2024 | |
| Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross | 04/25/2024 | |
| Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide | 04/21/2024 | |
| Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies | 04/24/2024 | |
| What's the Deal with Saturated Fat and Cardiovascular Disease Risk? | 04/24/2024 | |
| Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines | 04/22/2024 | |
| The Lipidology Essentials: Making of a Specialty's Annual Summary | 04/22/2024 | |
| Clinical Decisions on Cardiovascular Disease: Are Risks or Causes Your Guide? | 04/21/2024 | |
| Pathways Toward Better Lipid Medication Adherence | 04/25/2024 | |
| Special Populations in Patient-Centered Management of Dyslipidemia | 04/24/2024 | |
| Dyslipidemia in The Elderly: How Old is "Too Old" to Treat? | 04/24/2024 | |
| Guidelines for Diagnosis and Management of Dyslipidemia in Patients with HIV | 04/23/2024 | |
| Updated NLA Recommendations for African American Patients | 04/24/2024 | |
| Dyslipidemia in Children and Adolescents | 04/24/2024 | |
| Million Hearts Initiative with Dr. Janet Wright, Executive Director | 04/18/2024 | |
| Dyslipidemia During Pregnancy: The Risks for Two Patients | 04/26/2024 | |
| Statin Intolerance: Keys to Patient Counseling and Guidance | 04/21/2024 | |
| Roles of Non-HDL Cholesterol in Risk Assessment and Treatment | 04/20/2024 | |
| Keys to the Latest NLA Recommendations for Dyslipidemia Treatments | 04/25/2024 | |
| Management of the Patient With Triglycerides 200-499 mg/dl. | 04/19/2024 | |
| What is the Safety of Statins in Patients with Diabetes? | 04/26/2024 | |
| A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines | 04/25/2024 | |
| National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia | 04/22/2024 | |
| New Insights on Statin Therapy for Older Patients | 04/24/2024 | |
| HPS-2 THRIVE Data and Results | 04/25/2024 | |
| Health Information Technology's Impact on Adherence to Lipid Therapy | 04/21/2024 | |
| Cardiometabolic Consequences of Sitting Time | 04/17/2024 | |
| Generics and Manufacturing: What Prescribers Need to Know | 04/25/2024 | |
| Genetic Testing for Familial Hypercholesterolemia | 04/25/2024 | |
| Research Updates in Familial Hypercholesterolemia | 04/26/2024 | |
| Research Updates on Postprandial Dyslipidemia Treatment | 02/25/2016 | |
| Lipid Biomarker Updates: When to Move Beyond the Standard Profile | 04/23/2024 | |
| What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Patie… | 04/23/2024 | |
| Adiposity, Obesity, and Dyslipidemia | 04/25/2024 | |
| Researching Oxidized High-Density Lipoprotein in Obese Adolescents | 04/26/2024 | |
| Underrecognition of Diabetes in Cardiology Practice | 04/25/2024 | |
| An Avocado a Day: Does It Keep Heart Disease Away? | 04/20/2024 | |
| The Impact of Inflammation on HDL Activity | 04/23/2024 | |
| Changing Nutritional Needs Throughout the Lifetime | 04/22/2024 | |
| Managing CVD in Women During Childbearing Years | 09/03/2015 | |
| Obesity, Diabetes and the Metabolic Syndrome | 03/06/2015 | |
| Broken Hearts or Broken Bones? | 04/19/2024 | |
| Non-pharmacologic Approaches to the Metabolic Syndrome and Diabetes | 09/25/2015 | |
| Evolving Treatments: A Review of What’s in the Pipeline | 06/14/2013 | |
| Fish Oils: Are They Still Cardioprotective? | 04/23/2024 | |
| Treatment Options for Polycystic Ovarian Syndrome (PCOS) | 04/20/2018 | |
| Controversy Surrounding the NHLBI Pediatric Guidelines | 04/26/2024 | |
| Statin Safety Considerations | 04/23/2024 | |
| Emerging LDL Therapies | 04/25/2024 | |
| Emerging HDL Therapies: What’s Next on the Clinical Research Horizon | 04/26/2024 | |
| Understanding Why Patients Discontinue Statin Therapy | 04/24/2024 | |
| Statin Therapy and Diabetes Incidence | 04/25/2024 | |
| Lipids and Hormone Therapy | 04/22/2024 | |
| Diet Controversies in Lipid Lowering & Cardiovascular Disease Prevention | 04/24/2024 | |
| Biomarkers and Lipidology | 04/23/2024 | |
| Diagnosis, Prevalence, and Screening of Familial Hypercholesterolemia | 04/22/2024 | |
| Fat, Exercise and Cholesterol | 04/18/2024 | |
| Managing Lipids in the Chronic Kidney Disease Patient | 04/23/2024 | |
| Coronary CT Angiography | 04/23/2024 | |
| Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease | 04/23/2024 | |
| Management Issues in Familial Hypercholesterolemia | 04/25/2024 | |
| Familial Hypercholesterolemia: Risk Stratifications in Practice | 04/21/2024 | |
| From Experts to Analytics: What Does Evidence-Based Medicine Mean? | 01/25/2013 | |
| CIMT Appropriate Use Guidelines | 04/22/2024 | |
| Personalizing Dietary Approaches for Cardiovascular Health | 04/24/2024 | |
| LDL Apheresis | 04/22/2024 | |
| Imaging Guidelines for Screening CV Risk | 04/15/2024 | |
| Fundamentals of Fatty Acids | 04/20/2024 | |
| It's Relative: Screening and Treating Familial Hypercholesterolemia | 04/24/2024 | |
| Caring for Un- and Under-Insured Patients on Lipid Therapy | 04/24/2024 | |
| Current Inquiries in Lipidology: The NLA's Role in the Field | 06/03/2011 | |
| Predictive Value of Lipid Biomarkers and Inflammatory Markers | 05/06/2011 | |
| The Importance of Omega-3 Fatty Acids | 04/10/2024 | |
| Metabolic Syndrome in African Americans: Risk Adjustments & Treatments | 04/25/2024 | |
| Atherosclerosis and Cardiovascular Risk Factors in Children | 04/23/2024 | |
| Cardiometabolic Risk Reduction in Native Americans | 04/23/2024 | |
| The Process of Developing Clinical Guidelines | 10/08/2010 | |
| Updates on the ACCORD Trial From the 2010 National Lipid Association Meeting | 10/01/2010 | |
| Lipid Management and Systemic Approaches to Patient Care | 09/10/2010 | |
| Heart Disease in the United States: Past, Present, and Future Trends | 10/15/2010 | |
| Behavioral Strategies for Managing Weight | 04/21/2024 | |
| Exercise as Medicine | 04/22/2024 | |
| Using HDL in the Clinical Setting | 04/23/2024 | |
| Particle Number Testing in the Prevention of Atherosclerosis | 04/23/2024 | |
| Strategies to Help Reduce Diseases Associated with Lifestyle | 04/25/2024 | |
| Reevaluating Heart Protective vs Destructive Dietary Fats | 04/24/2024 | |
| Dietary Fats and Cardiovascular Disease | 04/23/2024 | |
| Looking Beyond LDL to Reduce Cardiovascular Events | 11/02/2008 | |
| The Latest Targets of Lipid Therapy | 09/07/2008 | |
